Quarter Period Consolidated Statement Of Comprehensive Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7576262

Concept 2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
9,149,000,000 JPY
10,246,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
146,000,000 JPY
624,000,000 JPY
Remeasurements of defined benefit plans, net of tax
47,000,000 JPY
59,000,000 JPY
Other comprehensive income
193,000,000 JPY
684,000,000 JPY
Comprehensive income
9,343,000,000 JPY
10,930,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
9,343,000,000 JPY
10,930,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.